LeaveRussia: Ipsen is Pausing New Investments in Russia
Ipsen NHS Study Published - IFOPA - International Fibrodysplasia Ossificans Progressiva Association
Ipsen CEO David Loew is elected to EFPIA leadership; joins industry partners to warn of impact of EU pharma legislation - Global
Ipsen (@IpsenGroup) / X
Press Releases - Ipsen UK
Ipsen is officially recognized as a great place to work worldwide - Global
Ipsen Inc. | Aviation Pros
Press Releases - Ipsen UK
Press Releases / Melissa Peebles
Ipsen Goes All In on Neuro with $1 Billion+ Deal For Exicure's Oligonucleotides | BioSpace
IPSEN: Announces FDA Approval of Dysport® (abobotulinumtoxinA) for the Treatment of Upper Limb Spasticity in Children, Excluding Cerebral Palsy | FDA Reporter
06-01-2016-PR-Ipsen-Galderma-APAC-Dysport-Aesthetics
Mayoly Spindler completed the acquisition of Ipsen's CHC branch - MAYOLY SPINDLER laboratoire indépendant français
Press Releases - Ipsen UK
Ipsen: a dynamic, fast-growing specialty care powerhouse
Ipsen Adds Another Program Into Its Pre-Clinical R&D Oncology Pipeline Through an Exclusive Worldwide Collaboration With Accent Therapeutics, Targeting the RNA Modifying Protein, METTL3 | Business Wire
Pharma News and Updates | Ipsen, BioMarin, AbbVie, BMS, GSK, Novartis
Press releases
Ipsen CEO steers clear of gene therapy despite rare disease push
Press Releases - Ipsen UK
Press Releases - Ipsen UK
Ipsen media library
Ipsen's quick fix backfires | Evaluate
Ipsen puts patients first
Ipsen - David Meek appointed as Chief Executive Officer of Ipsen http://www. ipsen.com/wp-content/uploads/2016/07/11-07-2016-PR-David-Meek-new-CEO-of- Ipsen.pdf | Facebook
